Skip to main content

Share story

Science

Chinese university investigating girl's death in gene-editing trial

Chinese university investigating girl's death in gene-editing trial Image: Primary
A Chinese university said Sunday it is investigating reports that a gene-editing trial caused the death of a six-year-old girl, which was not disclosed in published research. Shanghai Jiao Tong University School of Medicine said in a statement that it attaches great importance to the matter and has set up a special working group to conduct a comprehensive investigation into the incident. The girl, given the pseudonym Mei, died last year around a week after receiving a spinal infusion of trillions of viruses designed to penetrate the brain for treatment, according to a joint investigation by Science and Retraction Watch published Thursday. The experimental gene therapy was meant to fix a rare genetic condition that caused a delay in cognitive development. Neuroscientist Zilong Qiu, the lead researcher, published a paper on related animal studies in the journal Nature that made no mention of Mei. The university said it firmly opposes conducting medical scientific research in violation of scientific research ethics and that serious action would be taken in accordance with the investigation's findings. Mei's parents, who paid more than $800,000 to fund the experiment, were not adequately informed about the risks, the report said. The previously undisclosed death is a fresh blow to China's ambitions to rival the United States as a biotech power following the 2018 scandal around He Jiankui.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from CNA and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Capital
AI Capital

OpenAI lowers funding valuation target to $1.25tn

OpenAI has lowered the valuation it seeks in a new funding round to $1.25tn from $1.4tn after some investors resisted the higher price, the Financial Times reported, citing documents it reviewed. The company is close to raising u...

Capital AI
Capital AI

Baba raises $40 million Series A led by FirstMark

Baba raised $40 million in Series A funding led by FirstMark, Fierce Healthcare reported. The company develops AI tools that help Medicare and Medicaid patients connect with care teams and handle advocacy tasks, focusing on their ...

AI
AI

Claude deploys fix for errors affecting multiple models and services

Claude's status page said a fix had been deployed at 06:35 UTC on October 25 for errors affecting its services, with recovery still being monitored. The incident affects claude.ai, the Claude API, Claude Code and Claude Cowork. T...